Australian Health Insurer NIB and Navigenics Team Up to Offer Cut-Rate Genetic Testing to NIB Customers
Australian patients are using an American clinical pathology laboratory for their genetic testing needs
It’s a half-price sale of genetic clinical laboratory tests for 5,000 customers of Australian health insurer NIB. NIB wants to encourage its beneficiaries to screen themselves to identify their genetic tendencies for such conditions as heart disease, diabetes, some cancers, and other diseases with a known genetic component.
NIB has arranged for California-based Navigenics to conduct the genetic tests for a price of US $499. That’s a 50% discount from Navigenics’ usual retail price of US $999.
